Summary
Dr.Nature, a natural nutrition brand under AUNEW Group, appeared at the 9th China International Import Expo (CIIE) and signed an exclusive agency agreement for the Asia-Pacific region with Haomei International Co. , Ltd. during the event, marking a strategic upgrade for the brand.
Linda, brand head of Dr.Nature, said the signing marks a new stage in building a localised channel system for the Chinese and Asia-Pacific markets, laying the foundation for subsequent market operations and consumer services. Xiang Xing, general manager of Haomei International, said the company will vigorously introduce natural nutrition products that meet TGA pharmaceutical-grade quality standards into China and the Asia-Pacific market. From 6 to 7 November, representatives from New Zealand and Australia visited the Dr.Nature booth to witness the cooperation.
Dr.Nature products are manufactured by AUNEW Group's own GMP Pharmaceuticals factory, which operates seven production bases across Australia and New Zealand, follows GMP manufacturing standards, holds 27 consecutive years of TGA certification, and carries AUSTL registration numbers for its full product range. Core products have obtained Australian Made kangaroo origin certification. The brand has been deeply engaged in the nutrition and health sector for 37 years, and its products have entered mainstream Australian pharmacy chains including Terry White Chemmart, Priceline and Chemist Warehouse.
The booth showcased three core products: Joint Formula, Respiratory Formula and Vitality Formula. Joint Formula contains glucosamine sulfate, New Zealand green-lipped mussel and MSC-certified shark cartilage, while Vitality Formula contains 2.9g of ginseng per serving. The Dr.Nature booth is located in Hall 7.1 (Booth 7.1B1-03) and continues to receive industry partners from home and abroad for discussions.
Commentary
Dr.Nature's signing of an Asia-Pacific exclusive agency agreement at the CIIE reflects a trend of Australian and New Zealand nutrition brands leveraging China's open platform to accelerate regional expansion. Backed by 27 consecutive years of TGA certification and mainstream Australian pharmacy channels, the brand has a differentiated quality advantage. However, competition in the Asia-Pacific market is intense, with brands such as Swisse and Blackmores already occupying strong positions, and China's cross-border e-commerce regulation is tightening.
For NZ small and medium-sized enterprises, this case suggests that platforms such as the CIIE can efficiently connect channel resources, but companies need to assess the transfer of control under an exclusive agency model and their localised operational capabilities. Meanwhile, the use of distinctive New Zealand ingredients such as green-lipped mussel in product formulations highlights the value of local resources in the health food sector, and relevant suppliers may watch for such brands' procurement demand for ingredients. Whether Dr.Nature can establish a firm foothold in the Asia-Pacific depends on the efficiency of its collaboration with the agent and its responsiveness to Chinese consumer preferences.
Keywords: Dr.Nature, CIIE, Asia-Pacific exclusive agency, Haomei International, AUNEW Group, TGA certification, natural nutrition products, New Zealand, localised expansion
Image for illustration purposes
Source: The Beijing News
Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.




